Harry K. Slocum

2.9k total citations
71 papers, 2.4k citations indexed

About

Harry K. Slocum is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Harry K. Slocum has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 31 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Harry K. Slocum's work include Biochemical and Molecular Research (8 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Cells and Metastasis (6 papers). Harry K. Slocum is often cited by papers focused on Biochemical and Molecular Research (8 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Cells and Metastasis (6 papers). Harry K. Slocum collaborates with scholars based in United States, Canada and Australia. Harry K. Slocum's co-authors include Youcef M. Rustum, William R. Greco, Zlatko P. Pavelić, Constantine P. Karakousis, Károly Tóth, Amy Early, Harvey D. Preisler, Raymond M. Baker, Robert P. Huben and Dongfeng Tan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Analytical Biochemistry.

In The Last Decade

Harry K. Slocum

70 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry K. Slocum United States	27	1.1k	1.0k	479	471	314	71	2.4k
C.L. van der Wilt Netherlands	25	1.6k 1.4×	1.2k 1.2×	342 0.7×	508 1.1×	257 0.8×	60	2.7k
Christian M. Kurbacher Germany	27	1.1k 1.0×	724 0.7×	430 0.9×	347 0.7×	213 0.7×	92	2.3k
A H Calvert United Kingdom	34	2.0k 1.8×	1.9k 1.8×	443 0.9×	719 1.5×	196 0.6×	89	3.7k
Henk J. Broxterman Netherlands	26	1.3k 1.2×	1.4k 1.4×	470 1.0×	379 0.8×	169 0.5×	51	2.8k
Kees Smid Netherlands	29	1.7k 1.6×	1.5k 1.4×	506 1.1×	606 1.3×	316 1.0×	90	3.1k
Paul Noordhuis Netherlands	32	1.7k 1.5×	1.4k 1.3×	412 0.9×	506 1.1×	235 0.7×	82	3.4k
C.J. van Groeningen Netherlands	28	1.4k 1.2×	983 0.9×	288 0.6×	483 1.0×	279 0.9×	51	2.4k
Kevin J. Scanlon United States	32	1.1k 1.0×	1.8k 1.8×	238 0.5×	244 0.5×	207 0.7×	84	2.8k
David A. Van Echo United States	26	1.5k 1.3×	916 0.9×	171 0.4×	437 0.9×	322 1.0×	71	3.0k
Jin S. Lee United States	30	1.2k 1.1×	1.3k 1.3×	466 1.0×	960 2.0×	472 1.5×	60	3.4k

Countries citing papers authored by Harry K. Slocum

Since Specialization

Citations

This map shows the geographic impact of Harry K. Slocum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry K. Slocum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry K. Slocum more than expected).

Fields of papers citing papers by Harry K. Slocum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry K. Slocum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry K. Slocum. The network helps show where Harry K. Slocum may publish in the future.

Co-authorship network of co-authors of Harry K. Slocum

This figure shows the co-authorship network connecting the top 25 collaborators of Harry K. Slocum. A scholar is included among the top collaborators of Harry K. Slocum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry K. Slocum. Harry K. Slocum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chintala, Sreenivasulu, Károly Tóth, Arup Bhattacharya, et al.. (2010). Downregulation of Cystine Transporter x<sub>c</sub><sup>–</sup> by Irinotecan in Human Head and Neck Cancer FaDu Xenografts. Chemotherapy. 56(3). 223–233. 14 indexed citations

2.

Ling, Xiang, Jie Yang, Nithya Ramnath, et al.. (2005). Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer. 49(3). 353–361. 38 indexed citations

3.

Ramnath, Nithya, Nikhil I. Khushalani, Károly Tóth, et al.. (2005). S-phase modulation by irinotecan: pilot studies in advanced solid tumors. Cancer Chemotherapy and Pharmacology. 56(5). 447–454. 11 indexed citations

4.

Deeb, George, Jianmin Wang, Nithya Ramnath, et al.. (2004). Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Modern Pathology. 17(4). 430–439. 62 indexed citations

5.

Tan, Dongfeng, Sam M. Wiseman, Qiang Li, et al.. (2004). Definition of a Region of Loss of Heterozygosity at Chromosome 11q23.3-25 in Head and Neck Squamous Cell Carcinoma Using Laser Capture Microdissection Technique. Diagnostic Molecular Pathology. 13(1). 33–40. 5 indexed citations

6.

Tan, Dongfeng, George Deeb, Jianmin Wang, et al.. (2003). HER-2/ neu Protein Expression and Gene Alteration in Stage I-IIIA Non???Small-Cell Lung Cancer: A Study of 140 Cases Using a Combination of High Throughput Tissue Microarray, Immunohistochemistry, and Fluorescent In Situ Hybridization. Diagnostic Molecular Pathology. 12(4). 201–211. 66 indexed citations

7.

Tan, Dongfeng, Qiang Li, Nithya Ramnath, et al.. (2003). Loss of cables protein expression in human non–small cell lung cancer: A tissue microarray study. Human Pathology. 34(2). 143–149. 25 indexed citations

8.

Guo, Bin, U. Vanhoefer, Rami G. Azrak, et al.. (2000). Characterization of Protein Kinase chk1 Essential for the Cell Cycle Checkpoint after Exposure of Human Head and Neck Carcinoma A253 Cells to a Novel Topoisomerase I Inhibitor BNP1350. Molecular Pharmacology. 57(3). 453–459. 3 indexed citations

9.

Guo, Bin, U. Vanhoefer, Rami G. Azrak, et al.. (2000). Characterization of Protein Kinase chk1 Essential for the Cell Cycle Checkpoint after Exposure of Human Head and Neck Carcinoma A253 Cells to a Novel Topoisomerase I Inhibitor BNP1350. Molecular Pharmacology. 57(3). 453–459. 21 indexed citations

10.

Slocum, Harry K., et al.. (1998). Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.. PubMed. 58(24). 5749–61. 89 indexed citations

11.

Gibbs, John F., et al.. (1994). Cellular heterogeneity in DNA damage and growth inhibition induced by ICI D1694, thymidylate synthase inhibitor, using single cell assays. Biochemical Pharmacology. 48(5). 997–1002. 16 indexed citations

12.

Malmberg, Martin, Harry K. Slocum, & Youcef M. Rustum. (1993). Growth slow‐down and growth arrest of human colon carcinoma cells HCT‐8 in vitro after exposure to 5‐fluoro‐2′‐deoxyuridine. Cell Proliferation. 26(3). 291–303. 4 indexed citations

13.

Chang, Sung‐Goo, Károly Tóth, Jennifer D. Black, et al.. (1992). Growth of human renal cortical tissue on collagen gel. In Vitro Cellular & Developmental Biology - Animal. 28(2). 128–135. 4 indexed citations

14.

Slocum, Harry K., Martin Malmberg, William R. Greco, John Carmi Parsons, & Youcef M. Rustum. (1990). The determination of growth rates of individual colonies in agarose using high‐resolution automated image analysisx. Cytometry. 11(7). 793–804. 10 indexed citations

15.

Gerlach, James H., David R. Bell, Constantine P. Karakousis, et al.. (1987). P-glycoprotein in human sarcoma: evidence for multidrug resistance.. Journal of Clinical Oncology. 5(9). 1452–1460. 226 indexed citations

16.

Slocum, Harry K., et al.. (1980). An enzymatic method for the disaggregation of human solid tumors for studies of clonogenicity and biochemical determinants of drug action.. PubMed. 48. 339–43. 20 indexed citations

17.

Roth, Jack A., Harry K. Slocum, Michele Pellegrino, E. Carmack Holmes, & Ralph A. Reisfeld. (1976). Purification of soluble human melanoma-associated antigens.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(7 PT 1). 2360–4. 22 indexed citations

18.

Hakala, Maire, et al.. (1975). N⁶‐(Δ²‐Isopentenyl)adenosine, an inhibitor of cellular transport of uridine and cytidine. Journal of Cellular Physiology. 86(2). 281–291. 7 indexed citations

19.

Slocum, Harry K., et al.. (1974). N6-(Δ2-Isopentenyl)adenosine 5'-Monophosphate: Formation and Effect on Purine Metabolism in Cellular and Enzymatic Systems. Molecular Pharmacology. 10(3). 529–543. 4 indexed citations

20.

Slocum, Harry K., et al.. (1974). N6-(delta2-isopentenyl)adenosine 5'-monophosphate: formation and effect on purine metabolism in cellular and enzymatic systems.. PubMed. 10(3). 529–43. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact